Clobetasol and condition aggravated Patient Reports February 11, 2012
Clobetasol Side Effects Report #4850672-2
Clobetasol side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 28, 2005. Male patient, 62 years of age, weighting 185.0 lb, was diagnosed with pemphigoid and was treated with Clobetasol. After drug was administered, patient experienced the following side effects: adrenal mass, condition aggravated, lung disorder, off label use, pneumonia
. Clobetasol dosage: unknown. During the same period patient was treated with CELLCEPT, LIPITOR, PREDNISONE, MONOPRIL. Patient was hospitalized. Patient recovered.Clobetasol Side Effects Report #5008922-8
Clobetasol side effect was reported by a Consumer or non-health professional from UNITED STATES on May 17, 2006. Male patient, 74 years of age, weighting 220.0 lb, was diagnosed with lichen sclerosus and was treated with Clobetasol. After drug was administered, patient experienced the following side effects: condition aggravated, penis disorder
, skin infection. Clobetasol dosage: unknown. Patient was hospitalized. Patient recovered.Clobetasol Side Effects Report #5028322-4
Clobetasol side effect was reported by a Consumer or non-health professional from UNITED STATES on June 13, 2006. Male patient, 74 years of age, weighting 220.0 lb, was diagnosed with lichen sclerosus and was treated with Clobetasol. After drug was administered, patient experienced the following side effects: condition aggravated, penile infection, prepuce redundant. Clobetasol dosage: unknown. Patient was hospitalized. Patient recovered.
Clobetasol Side Effects Report #5478857-5
Clobetasol side effect was reported by a Physician from TURKEY on Aug 31, 2007. Female patient, 48 years of age, was diagnosed with eczema
and was treated with Clobetasol. After drug was administered, patient experienced the following side effects: condition aggravated, cushing's syndrome, skin candida. Clobetasol dosage: unknown. Patient recovered.
Clobetasol and condition aggravated 